Ashland Shanghai Laboratory: Rosaliss can repair acne
Ashland, a global specialty chemicals company, recently conducted a clinical study of Rosaliss, a biological functional ingredient of Provencal Chiba Rose, in the Shanghai laboratory, and announced new research results.
At the Ashland Clinical Laboratory in Shanghai, 35 volunteers participated in the study. The first group of volunteers had age spots on their faces, and their skin was sagging. The second group had acne blemishes or acne marks. They tried a face cream containing 1% Rosaliss for 28 days.
The research results show that Rosaliss bio-functional ingredients can repair acne damage on the skin, make the skin brighter and more balanced, the skin texture looks smoother, fine lines are reduced, and pores are reduced. The skin is more radiant, more supple and firm.
At the same time, blemishes including acne marks are reduced, and the "sensitivity" of the skin is reduced.
Rosaliss biological functional ingredients are natural extracts produced by Ashland using plant small molecule RNA patented technology. This technology allows Ashland to extract active ingredients from fresh petals.
Chuanwei Chemical's VAE debuts in Europe
2026-09-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Ashland Advances $60 Million Strategic Manufacturing Network Optimization
-
Ashland Completes Sale of Its Avoca Business to Mane
-
Ashland Signs Definitive Agreement to Sell Its Avoca Business to Mane
-
Ashland sells nutraceutical business to Turnspire Capital Partners
-
Ashland Launches Perfectyl Biofunctional for Clear Skin, Utilizes GABA Amino Acid
-
The Gen Z-focused skin care brand [coat]s Makes Striking US Debut on Amazon and CVS
-
Skincare Dominates in in-cosmetics Asia Awards for 2023
-
Crodarom Enhances Skin Barrier with Phytessence French Rose EC
-
Lanxess Unveils Neolone BioG Preservative: A Sustainable Shield
-
Lipoid Kosmetik Introduces Immortelle Oil Pro - A Clinically Validated Extract for Smooth and Toned Skin
Recommend Reading
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
BASF Pushes Triple-Action Weed Control
-
BASF Pushes Triple-Action Weed Control
-
Syngenta Caught in Trade Crossfire
-
Pre-holiday Dichloromethane Price Increase Fails to Continue
-
MTBE Market Prices Fluctuate Narrowly
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses
-
MTBE Market Prices Continue to Decline
-
Post-holiday Increase in Acetone Market Inventory Volume and the Struggle for a Good Start in China